Cordatus Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $405K | Sell |
5,868
-106
| -2% | -$7.32K | 0.1% | 124 |
|
|
2025
Q1 | $415K | Buy |
5,974
+484
| +9% | +$33.6K | 0.11% | 113 |
|
|
2024
Q4 | $472K | Buy |
5,490
+18
| +0.3% | +$1.55K | 0.12% | 107 |
|
|
2024
Q3 | $652K | Hold |
5,472
| – | – | 0.23% | 69 |
|
|
2024
Q2 | $781K | Buy |
+5,472
| New | +$781K | 0.29% | 65 |
|
|
2023
Q3 | – | Sell |
-6,160
| Closed | -$498K | – | 116 |
|
|
2023
Q2 | $498K | Buy |
+6,160
| New | +$498K | 0.19% | 92 |
|
|
2022
Q3 | – | Sell |
-10,980
| Closed | -$612K | – | 125 |
|
|
2022
Q2 | $612K | Sell |
10,980
-5,354
| -33% | -$298K | 0.29% | 107 |
|
|
2022
Q1 | $907K | Buy |
+16,334
| New | +$907K | 0.32% | 112 |
|